Acquired Hemophilia Treatment Market Driven by Rare Disease Care
The Acquired Hemophilia Treatment Market was valued at US$ 1.17 Billion in 2025 and is projected to reach US$ 1.84 Billion by 2034, expanding at a CAGR of 5.14% during 2026–2034. The market is driven by increasing awareness of rare bleeding disorders, …